Secondary thigh telangiectasias after endovenous laser ablation of the great saphenous vein
Rattachement africain : ru, kz. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Objectives To assess the incidence of secondary telangiectasias (TAEs) after endovenous laser ablation (EVLA) of the great saphenous vein (GSV) and discuss the possible risk factors for its development. Method This prospective observational study enrolled 123 lower limbs of 103 patients with varicose veins of C2 or C4 clinical classes who underwent EVLA of the GSV trunk from the saphenofemoral junction to the below knee level without simultaneous removal of varicose tributaries and/or perforating veins. The primary outcome was the occurrence and amount of secondary TAEs (matting) that developed at the medial aspect of the thigh along the treated GSV within a 3-month follow-up. The assessment was made by analysis of before and after photos by three experienced surgeons using a four-point scale. Fleiss’ Kappa was used to measure the agreement between the assessors. Results Secondary TAE development was reported in 26 limbs (21.1%; 95% CI, 15.0-29.0%). Almost perfect agreement was observed between assessors for any matting (κ = 0.92; p < .0001) and different amounts of it (κ = 0.93, κ = 0.90, κ = 0.85, and κ = 1.00 for the score of 0, 1, 2, and 3, respectively). The most prevalent was a low amount of new TAEs (score of 1 in 17.9%). The only significant difference between the patients with and without secondary TAEs was age: 52.5 (IQR, 43-61) versus 40 (IQR, 34-53) years old. Conclusions In most cases (96,8%), secondary TAEs are either absent or could be found in a low amount. Older patients are more predisposed to its development.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Secondary thigh telangiectasias after endovenous laser ablation of the great saphenous vein
- Date Crossref
- 11/06/2025
- Éditeur
- SAGE Publications
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Chelyabinsk State Medical Academy pays non établi dans la noticeUniversité ou école supérieure
-
Kazakhstan Medical University pays non établi dans la noticeUniversité ou école supérieure
-
Pirogov Russian National Research Medical University pays non établi dans la noticeUniversité ou école supérieure
-
Kaliningrad State Technical University pays non établi dans la noticeUniversité ou école supérieure
-
Kazakhstan-Russian Medical University pays non établi dans la noticeUniversité ou école supérieure
-
South Ural State Medical University pays non établi dans la noticeUniversité ou école supérieure
-
Phlebocenter Kaliningrad LLC pays non établi dans la noticeInstitution
-
Research Laboratory of Venous Hemodynamics pays non établi dans la noticeStructure de recherche
-
Ozon Pharmaceuticals PJSC pays non établi dans la noticeInstitution
Chelyabinsk State Medical Academy, Kazakhstan Medical University et Pirogov Russian National Research Medical University, avec 6 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.